Skip to main content
OpenTrials
Completed

NCT Number: NCT00694239

Risk Assessment and Treat Compliance in Hypertension Education Trial

The RATCHET study assesses if patient knowledge of estimated cardiovascular risk at current and recommended target blood pressure levels improves compliance in the management of hypertension.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hypertension Behavior Cardiovascular Diseases Dyslipidemia Dyslipidemias Health Behavior Lipid Metabolism Disorders Metabolic Diseases Nutritional and Metabolic Diseases Patient Acceptance of Health Care Patient Compliance Treatment Adherence and Compliance Vascular Diseases

Age range

30 year–84 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Western Ontario

London, Ontario, N6A 5A5, Canada

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Essential hypertension (new diagnosis or established diagnosis) meeting criteria for pharmacologic therapy as defined by current guidelines

Exclusion criteria

  • Lack of written informed consent
  • Previous myocardial infarction
  • Previous stroke
  • Congestive heart failure
  • Stage 3 or greater chronic kidney disease
  • Pregnancy
  • Usage of medication bubble/blister package

Treatment and study plan

Knowledge of Cardiovascular Risk Assessment

Behavioral

Knowledge of Cardiovascular Risk Assessment and risk reduction at target BP, reviewed every 3-6 months.

Primary outcomes

  1. Medication Compliance

    Time frame: 1 year

Secondary outcomes

  1. Patient perception of cardiovascular risk

    Time frame: 1 year

  2. Pilot Feasibility Study

    Time frame: 1 year

  3. Blood Pressure

    Time frame: 1 year

  4. Cholesterol Level

    Time frame: 1 year

  5. Framingham Risk Score (stroke and coronary artery disease)

    Time frame: 1 year

Sponsors and collaborators

Lead sponsor

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Other

Collaborators

  • The Physicians' Services Incorporated Foundation
  • University of Western Ontario, Canada

Registry information

Official study title

Evaluation of the Effect of Cardiovascular Risk Assessment in Treatment Compliance in Hypertension

Acronym: RATCHET

Important dates

Study start
2007
Primary completion
2011
Study completion
2011
First posted
Jun 10, 2008
Registry last updated
Jun 30, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.